Literature DB >> 11152501

Cloning and sequencing of defective particles derived from the autonomous parvovirus minute virus of mice for the construction of vectors with minimal cis-acting sequences.

N Clément1, B Avalosse, K El Bakkouri, T Velu, A Brandenburger.   

Abstract

The production of wild-type-free stocks of recombinant parvovirus minute virus of mice [MVM(p)] is difficult due to the presence of homologous sequences in vector and helper genomes that cannot easily be eliminated from the overlapping coding sequences. We have therefore cloned and sequenced spontaneously occurring defective particles of MVM(p) with very small genomes to identify the minimal cis-acting sequences required for DNA amplification and virus production. One of them has lost all capsid-coding sequences but is still able to replicate in permissive cells when nonstructural proteins are provided in trans by a helper plasmid. Vectors derived from this particle produce stocks with no detectable wild-type MVM after cotransfection with new, matched, helper plasmids that present no homology downstream from the transgene.

Entities:  

Mesh:

Year:  2001        PMID: 11152501      PMCID: PMC114034          DOI: 10.1128/JVI.75.3.1284-1293.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

Review 1.  Replication fork arrest and DNA recombination.

Authors:  B Michel
Journal:  Trends Biochem Sci       Date:  2000-04       Impact factor: 13.807

2.  Incomplete genomes of the parvovirus minute virus of mice: selective conservation of genome termini, including the origin for DNA replication.

Authors:  E A Faust; D C Ward
Journal:  J Virol       Date:  1979-10       Impact factor: 5.103

3.  Rolling hairpin model for replication of parvovirus and linear chromosomal DNA.

Authors:  P Tattersall; D C Ward
Journal:  Nature       Date:  1976-09-09       Impact factor: 49.962

4.  DNA sequence of the lymphotropic variant of minute virus of mice, MVM(i), and comparison with the DNA sequence of the fibrotropic prototype strain.

Authors:  C R Astell; E M Gardiner; P Tattersall
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

5.  Construction of an infectious molecular clone of the autonomous parvovirus minute virus of mice.

Authors:  M J Merchlinsky; P J Tattersall; J J Leary; S F Cotmore; E M Gardiner; D C Ward
Journal:  J Virol       Date:  1983-07       Impact factor: 5.103

6.  Nonhomologous recombination in the parvovirus chromosome: role for a CTATTTCT motif.

Authors:  A Hogan; E A Faust
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

7.  Recombination within the nonstructural genes of the parvovirus minute virus of mice (MVM) generates functional levels of wild-type NS1, which can be detected in the absence of selective pressure following transfection of nonreplicating plasmids.

Authors:  J L Pearson; D J Pintel
Journal:  Virology       Date:  2000-03-30       Impact factor: 3.616

8.  Defective interfering particles of parvovirus H-1.

Authors:  S L Rhode
Journal:  J Virol       Date:  1978-08       Impact factor: 5.103

9.  DNA sequence of the 5' terminus containing the replication origin of parvovirus replicative form DNA.

Authors:  S L Rhode; B Klaassen
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

10.  DNA sequence comparison between two tissue-specific variants of the autonomous parvovirus, minute virus of mice.

Authors:  R Sahli; G K McMaster; B Hirt
Journal:  Nucleic Acids Res       Date:  1985-05-24       Impact factor: 16.971

View more
  2 in total

1.  Within-host genetic diversity of endemic and emerging parvoviruses of dogs and cats.

Authors:  Karin Hoelzer; Laura A Shackelton; Edward C Holmes; Colin R Parrish
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

Review 2.  Recombination in eukaryotic single stranded DNA viruses.

Authors:  Darren P Martin; Philippe Biagini; Pierre Lefeuvre; Michael Golden; Philippe Roumagnac; Arvind Varsani
Journal:  Viruses       Date:  2011-09-13       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.